10-K: Cambridge Acquisition Corp. Details IPO, SPAC Structure

Cambridge Acquisition Corp.'s 2025 Annual Report outlines its blank check company structure, successful IPO, and strategy to acquire high-growth businesses in underserved markets.

Summary

• Cambridge Acquisition Corp. (CAQ) is a Cayman Islands exempted blank check company formed to effect a Business Combination.
• The company consummated its Initial Public Offering (IPO) on February 9, 2026, raising $230,000,000 by selling 23,000,000 units at $10.00 per unit.
• Simultaneously, it completed a private sale of 495,500 Private Placement Units to its Sponsor for $4,955,000.
• A total of $230,000,000 from the IPO and private placement proceeds was placed in a Trust Account.
• The company has until February 9, 2028 (24 months from IPO) to complete an initial Business Combination.
• Management's strategy focuses on high-growth, recession-resilient subsectors transitioning from misunderstood to mainstream markets, leveraging their expertise and network.
• The company reported a net loss of $63,178 for the period from October 24, 2025 (inception) through December 31, 2025, primarily due to formation and administrative costs.
• As of December 31, 2025, the company had no cash and a working capital deficit of $101,914.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a standard SPAC 10-K, detailing the successful completion of its IPO and outlining its strategy. The established Trust Account and experienced management are positives, but the inherent risks of a blank check company and potential dilution for public shareholders temper overall sentiment.

Positives

• Successfully completed its Initial Public Offering on February 9, 2026, raising $230,000,000.
• Secured an additional $4,955,000 through a private placement to its Sponsor.
• A substantial portion of the proceeds ($230,000,000) is held in a Trust Account for the Business Combination.
• Management Team possesses a proven track record in stigmatized and underserved markets, deep sector expertise, and an extensive network.
• The SPAC structure offers an alternative, potentially less expensive and more certain path to public listing for target businesses.
• The company has a clear business strategy to target category-defining businesses in high-growth, recession-resilient subsectors.

Negatives

• The company is a blank check company with no operating history or revenues to date, relying solely on completing a Business Combination.
• Public Shareholders incurred immediate and substantial dilution due to the Sponsor acquiring Founder Shares at a nominal price ($0.003 per share).
• Potential for further dilution from the exercise of Private Placement Warrants and conversion of Working Capital Loans.
• Management and Sponsor have potential conflicts of interest in identifying and evaluating target businesses.
• The company's success depends entirely on the future performance of a single business post-combination, leading to a lack of diversification.
• A significant working capital deficit of $101,914 as of December 31, 2025, prior to IPO proceeds being fully available for operations.

Risks

• Inability to complete an initial Business Combination within the 24-month Combination Period (by February 9, 2028), leading to redemption of Public Shares and worthless Warrants.
• Difficulty obtaining additional financing for a Business Combination or target operations.
• Issuance of Ordinary Shares at a price less than the prevailing market price during a Business Combination, diluting existing shareholders.
• Public Shareholders may not have an opportunity to vote on the proposed Business Combination, and Founder Share holders' votes may lead to approval even if a majority of Public Shareholders do not support it.
• Increased competition for attractive target businesses due to a growing number of SPACs, potentially increasing acquisition costs or making it harder to find a target.
• Risk of wasting resources on researching uncompleted Business Combinations.
• Impact of global geopolitical conditions (Russia-Ukraine conflict, Middle East) on the search for a target or target company performance.
• Potential for the company to be deemed an investment company under the Investment Company Act, leading to burdensome compliance and restricted activities.
• The ability of Public Shareholders to redeem a large number of shares and the payment of deferred underwriting fees may limit the company's ability to complete the most desirable Business Combination or optimize its capital structure.
• Lack of business diversification post-combination, making the company dependent on a single business.
• Potential for the company to be a passive foreign investment company (PFIC), resulting in adverse U.S. federal income tax consequences for U.S. shareholders.
• The nominal purchase price paid by the Sponsor for Founder Shares may result in significant dilution to Public Shareholders and substantial profit for the Sponsor even if Public Shares decline.
• Warrants may have an adverse effect on the market price of Class A Ordinary Shares and make it more difficult to effectuate a Business Combination.
• Redemption of unexpired warrants prior to their exercise at a disadvantageous time, making them worthless.
• Cybersecurity incidents or attacks could result in information theft, data corruption, operational disruption, and financial loss.
• Changes in laws or regulations, or failure to comply, may adversely affect the business.
• Conflicts of interest for officers and directors due to other business affiliations and their substantial interest in the company.

Future Outlook

The company intends to identify and complete an initial Business Combination by February 9, 2028, focusing on high-growth, recession-resilient subsectors. It plans to leverage its management team's expertise and network to source proprietary opportunities and support the post-combination entity's strategic execution. The company may seek additional financing for larger acquisitions and will continue to incur public company expenses.

Management Comments

• Our Management Team is led by Brent Michael Cox, our Director and Chief Executive Officer and Anthony Michael Naimo, our Chief Financial Officer, with a background in high-growth, recession-resilient subsectors that are transitioning from misunderstood or underserved to mainstream markets.
• We believe there is a compelling opportunity to identify and partner with category-defining businesses operating in high-growth, recession-resilient subsectors that are transitioning from misunderstood to mainstream.
• Our strategy is to leverage the proven investment track record, deep sector expertise and extensive network of our Management Team to complete an initial Business Combination with a target company positioned to benefit from our operational guidance, capital resources and public market access.
• We intend to target businesses that are disrupting trillion-dollar legacy markets through harm-reduction innovation, wellness-oriented products and technology-enabled platforms.
• We believe our structure will make us an attractive Business Combination partner to prospective target businesses that desire to become a publicly listed company.

Industry Context

StockSavvy.ai notes that Cambridge Acquisition Corp. operates within the highly competitive SPAC market, which has seen increased scrutiny and volume volatility. The company's focus on 'high-growth, recession-resilient subsectors that are transitioning from misunderstood to mainstream' aligns with a broader trend of investors seeking disruptive innovation, particularly in areas like wellness, harm reduction, and technology-enabled platforms. However, the negative public perception of SPAC mergers and the increasing number of blank check companies could intensify competition for attractive targets, potentially impacting acquisition costs and the ability to find a suitable partner, a common challenge in the current SPAC landscape.

Comparison to Industry Standards

• The company's IPO structure, offering one Class A Ordinary Share and one-third of a warrant per unit, is a common SPAC model, comparable to many other SPACs listed on Nasdaq.
• The 24-month combination period (until February 9, 2028) is standard for SPACs, though Nasdaq also has a 36-month requirement for completing a business combination.
• The redemption price of $10.00 per Public Share from the Trust Account is typical, reflecting the initial unit price.
• The nominal price paid by the Sponsor for Founder Shares ($0.003 per share) and the resulting potential for significant dilution to public shareholders is a standard feature and a point of contention in the SPAC industry, often leading to criticism regarding sponsor economics.
• The management team's stated expertise in "stigmatized and under-served markets" and specific past investments (e.g., JUUL, Compass Pathways, MindMed) positions them in a niche that seeks to differentiate from generalist SPACs, similar to sector-specific SPACs that leverage deep industry knowledge.

Management Changes

Corporate Governance

Legal Proceedings

• To the knowledge of management, there is no material litigation currently pending or contemplated against the company, any of its officers or directors in their capacity as such, or against any of its property.

Related Party Transactions

• On October 30, 2025, the Sponsor purchased 7,666,667 Class B Ordinary Shares for $25,000 (approximately $0.003 per share).
• The company will pay $15,000 per month to affiliates of its Chairman and Chief Executive Officer for advisory services, accrued and payable only upon successful completion of the initial Business Combination.
• The Sponsor purchased 495,500 Private Placement Units for $4,955,000 in a private placement simultaneous with the IPO.
• The company will reimburse the Sponsor or an affiliate $10,000 per month for office space, utilities, and administrative support.
• The Sponsor or affiliates may loan the company Working Capital Loans (up to $1,500,000 convertible into Private Placement Units) to finance transaction costs, repayable upon Business Combination or from working capital outside the Trust Account if no Business Combination.
• The Sponsor, officers, and directors have waived redemption rights for their Founder Shares and Private Placement Shares and rights to liquidating distributions from the Trust Account for these shares if a Business Combination is not completed.
• The Sponsor has agreed to indemnify the company if third-party claims reduce the Trust Account below $10.00 per Public Share (with exceptions).
• Management Team members have indirect interests in the Founder Shares held by the Sponsor (e.g., Michael Cam-Phung, Brent Michael Cox, Anthony Michael Naimo).
• On February 4, 2026, the Sponsor assigned 150,000 Founder Shares (membership interests equivalent) to three independent directors for their services, vesting upon Business Combination.

Stakeholder Impact

• Shareholders (Public): Face immediate and substantial dilution from Founder Shares, potential for further dilution from warrants and Working Capital Loans, and limited voting rights on director appointments pre-Business Combination. They have redemption rights at IPO price plus interest if a Business Combination is completed or if the company liquidates without one.
• Shareholders (Sponsor/Management): Hold Founder Shares at a nominal price, providing significant upside potential if a Business Combination is successful, even if Public Shares decline. They have significant control over the company's direction and board appointments pre-Business Combination.
• Employees: Currently, only two officers (CEO, CFO) and no full-time employees. Post-Business Combination, new employees will be part of the combined entity.
• Customers/Suppliers: Not directly impacted by this SPAC's organizational filing, but will be relevant to the target business chosen for the Business Combination.
• Creditors: The Trust Account is generally protected from creditor claims, but there's a risk that claims could reduce the funds available for Public Share redemptions if waivers are not obtained or enforceable, or if the Sponsor cannot satisfy indemnification obligations.

Next Steps

• Identify and consummate an initial Business Combination with one or more businesses or entities.
• File a post-effective amendment to the IPO Registration Statement or a new registration statement covering Class A Ordinary Shares issuable upon exercise of Warrants within 20 business days after closing of the initial Business Combination.
• Maintain a current prospectus for Class A Ordinary Shares issuable upon exercise of Warrants until their expiration.
• Evaluate internal control procedures for the fiscal year ending December 31, 2026.
• Potentially seek shareholder approval to extend the Combination Period if needed.

Key Dates

Recommendation

As a blank check company that has just completed its IPO, Cambridge Acquisition Corp. has no operating business or revenue. The filing primarily details its organizational structure, IPO proceeds, and the framework for its future business combination. While the management team's stated expertise and the capital in the Trust Account are positive, the inherent risks of a SPAC, including the uncertainty of finding a suitable target and potential dilution, mean that there is no fundamental operating performance to evaluate for a 'buy' or 'sell' recommendation. Investors should 'hold' and await further developments regarding a potential business combination target.

Keywords

SPAC, Blank Check Company, Business Combination, IPO, Warrants, Class A Ordinary Shares, Trust Account, SEC Filing, Financial Reporting, Corporate Governance, Risk Factors, Acquisition, Cayman Islands, Nasdaq, Dilution, Founder Shares, Private Placement